ÈËÆÞÖгöÊÓƵ

Rebecca G. Kim, MAS
( out of 29 reviews )

Rebecca G. Kim, MAS, MD

Languages spoken: English

Clinical Locations

Redwood ÈËÆÞÖгöÊÓƵ Center

Salt Lake City
801-213-9900

  • Clinical Profile

    Rebecca G Kim, MD, MAS is a transplant and general hepatologist at the ÈËÆÞÖгöÊÓƵ of Utah School of Medicine. She specializes in the care of patients with chronic liver disease, cirrhosis, patients being evaluated for a liver transplant and those who have received a liver transplant. Dr. Kim grew up in Salt Lake, and then traveled around the country for her training. She received her medical degree from the ÈËÆÞÖгöÊÓƵ of Cincinnati College of Medicine and completed her internal medicine residency at the ÈËÆÞÖгöÊÓƵ of California San Diego. She stayed in San Diego for an additional year to work as a Chief Medicine Resident, and then completed her gastroenterology and transplant hepatology fellowships at the ÈËÆÞÖгöÊÓƵ of California San Francisco.

    Dr. Kim feels passionately about caring for patients with any stage of liver disease and truly enjoys the long-term relationship she gets to build with her patients. She sees patients with viral, genetic, and autoimmune causes of liver disease, and specifically focuses on alcohol-associated liver disease and metabolic dysfunction-associated steatotic liver disease. She is also particularly interested in caring for and conducting research focused on patients with liver disease who also have social needs or unique barriers to healthcare access.

    Academic Profile

    Rebecca G Kim, MD, MAS is a health services researcher and hepatologist at the ÈËÆÞÖгöÊÓƵ of Utah School of Medicine. She obtained her medical degree at the ÈËÆÞÖгöÊÓƵ of Cincinnati and completed her residency, chief resident year, and gastroenterology and transplant hepatology fellowships in California at the ÈËÆÞÖгöÊÓƵ of California San Diego and ÈËÆÞÖгöÊÓƵ of California San Francisco, respectively. In San Francisco, she completed a research fellowship under the mentorship of Dr. Mandana Khalili and obtained a Master in Advanced Studies in clinical research with a specialization in Implementation Science. Her research focuses on health disparities observed among patients with chronic liver disease and outcomes related to liver disease, liver cancer, and liver transplant.

    She is currently working with co-mentors Jennifer Price, MD, PhD at the ÈËÆÞÖгöÊÓƵ of California San Francisco, and Molly Conroy, MD, MPH and John Inadomi, MD at the ÈËÆÞÖгöÊÓƵ of Utah investigating the impact of social determinants of health (SDoH) on the risk and progression of chronic liver disease. Dr. Kim hopes to better understand how SDoH affect liver disease and how hepatology providers and the healthcare system may be able to help patients address SDoH to improve their liver health.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)
    American Board of Internal Medicine (Sub: Transplant Hepatology)

    Patient Rating

    4.8 /5
    ( out of 29 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 31, 2024
    UH HOSPITALS AND CLINICS

    Dr Kim is very helpful and courteous . Listens and answers all my comments and questions.

    July 10, 2024
    REDWOOD HEALTH CENTER

    Best visit I have had in 23 years at the U of U. Dr. KIM and her assitant are personable and professional. Thanks for making me feel like you do really care about me.

    July 05, 2024
    REDWOOD HEALTH CENTER

    She a very good doctor. One that I would go to because she very professional and listens to what I have to say. I'm very pleased with her.

    June 02, 2024
    UH HOSPITALS AND CLINICS

    Dr Kim takes great care and answers questions completely. She relays the treatment options in an understandable manner. I feel like I received superior care.

    April 11, 2024
    UH HOSPITALS AND CLINICS

    Rebecca is a excellent doctor.

    March 09, 2024
    REDWOOD HEALTH CENTER

    Dr. Rebecca Kim is a talented physician and surgeon and I would trust her again with my life

    March 05, 2024
    UH HOSPITALS AND CLINICS

    Thank you Rebecca for listening to my concerns

    February 23, 2024
    REDWOOD HEALTH CENTER

    Rebecca G Kim is excellent. She listened to my symptom and explain the treatment that she is giving to me to treat the Hepatitis B. She made sure I understood and her treatments. Thanks so much Dr. Rebecca.

    February 22, 2024
    REDWOOD HEALTH CENTER

    Very pleased with her care and knowledge

    See More Patient Comments

  • Clinical Profile

    Rebecca G Kim, MD, MAS is a transplant and general hepatologist at the ÈËÆÞÖгöÊÓƵ of Utah School of Medicine. She specializes in the care of patients with chronic liver disease, cirrhosis, patients being evaluated for a liver transplant and those who have received a liver transplant. Dr. Kim grew up in Salt Lake, and then traveled around the country for her training. She received her medical degree from the ÈËÆÞÖгöÊÓƵ of Cincinnati College of Medicine and completed her internal medicine residency at the ÈËÆÞÖгöÊÓƵ of California San Diego. She stayed in San Diego for an additional year to work as a Chief Medicine Resident, and then completed her gastroenterology and transplant hepatology fellowships at the ÈËÆÞÖгöÊÓƵ of California San Francisco.

    Dr. Kim feels passionately about caring for patients with any stage of liver disease and truly enjoys the long-term relationship she gets to build with her patients. She sees patients with viral, genetic, and autoimmune causes of liver disease, and specifically focuses on alcohol-associated liver disease and metabolic dysfunction-associated steatotic liver disease. She is also particularly interested in caring for and conducting research focused on patients with liver disease who also have social needs or unique barriers to healthcare access.

    Academic Profile

    Rebecca G Kim, MD, MAS is a health services researcher and hepatologist at the ÈËÆÞÖгöÊÓƵ of Utah School of Medicine. She obtained her medical degree at the ÈËÆÞÖгöÊÓƵ of Cincinnati and completed her residency, chief resident year, and gastroenterology and transplant hepatology fellowships in California at the ÈËÆÞÖгöÊÓƵ of California San Diego and ÈËÆÞÖгöÊÓƵ of California San Francisco, respectively. In San Francisco, she completed a research fellowship under the mentorship of Dr. Mandana Khalili and obtained a Master in Advanced Studies in clinical research with a specialization in Implementation Science. Her research focuses on health disparities observed among patients with chronic liver disease and outcomes related to liver disease, liver cancer, and liver transplant.

    She is currently working with co-mentors Jennifer Price, MD, PhD at the ÈËÆÞÖгöÊÓƵ of California San Francisco, and Molly Conroy, MD, MPH and John Inadomi, MD at the ÈËÆÞÖгöÊÓƵ of Utah investigating the impact of social determinants of health (SDoH) on the risk and progression of chronic liver disease. Dr. Kim hopes to better understand how SDoH affect liver disease and how hepatology providers and the healthcare system may be able to help patients address SDoH to improve their liver health.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)
    American Board of Internal Medicine (Sub: Transplant Hepatology)

    Education history

    Fellowship Advanced/Transplant Hepatology - ÈËÆÞÖгöÊÓƵ of California, San Francisco Fellow
    Hepatology - ÈËÆÞÖгöÊÓƵ of California, San Francisco Research Fellow
    Graduate Training Clinical Research with Specialization in Implementation Science - ÈËÆÞÖгöÊÓƵ of California, San Francisco M.A.S.
    Gastroenterology and Hepatology - ÈËÆÞÖгöÊÓƵ of California, San Francisco Fellow
    Residency Internal Medicine - ÈËÆÞÖгöÊÓƵ of California, San Diego School of Medicine Chief Resident
    Internal Medicine - ÈËÆÞÖгöÊÓƵ of California, San Diego School of Medicine Resident
    Professional Medical Medicine - ÈËÆÞÖгöÊÓƵ of Cincinnati College of Medicine M.D.
    Physiology - ÈËÆÞÖгöÊÓƵ of Cincinnati College of Medicine M.S.
    Undergraduate Biochemistry - Colgate ÈËÆÞÖгöÊÓƵ B.A.

    Selected Publications

    Journal Article

    1. Kim RG, Patel S, Satre DD, Shumway M, Chen JY, Magee C, Wong RJ, Monto A, Cheung R, Khalili M (2024). Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease. Dig Dis Sci. ()
    2. Medina SP, Kim RG, Magee C, Stapper N, Khalili M (2023). Cross-sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease. Obes Sci Pract, 9(6), 581-589. ()
    3. Morris MD, McDonell C, Kim RG, Laguardia Y, Kanner R, Price JC (2023). A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs. Clin Liver Dis (Hoboken), 22(3), 81-84. ()
    4. Kim RG, Kramer-Feldman J, Bacchetti P, Grimes B, Burchard E, Eng C, Hu D, Hellerstein M, Khalili M (2021). Disentangling the impact of alcohol use and hepatitis C on insulin action in Latino individuals. Alcohol Clin Exp Res, 46(1), 87-99. ()
    5. Kim RG, Medina SP, Magee C, Khalili M (2021). Fatty Liver and the Coronavirus Disease 2019 Pandemic: ÈËÆÞÖгöÊÓƵ Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations. Hepatol Commun. ()
    6. Akeno N, Reece AL, Callahan M, Miller AL, Kim RG, He D, Lane A, Moulton JS, Wikenheiser-Brokamp KA (2017). TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response. Mol Cancer Ther, 16(12), 2913-2926. ()
    7. Kim RG, Nguyen P, Bettencourt R, Dulai PS, Haufe W, Hooker J, Minocha J, Valasek MA, Aryafar H, Brenner DA, Sirlin CB, Loomba R (2016). Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study. Aliment Pharmacol Ther, 44(3), 287-99. ()
    8. Schurman SH, Dunn CA, Greaves R, Yu B, Ferrucci L, Croteau DL, Seidman MM, Bohr VA (2012). Age-related disease association of endogenous γ-H2AX foci in mononuclear cells derived from leukapheresis. PLoS One, 7(9), e45728. ()
    9. Nolen EG, Donahue LA, Greaves R, Daly TA, Calabrese DR (2008). Syntheses of alpha- and beta-C-glucopyranosyl serines from a common intermediate. Org Lett, 10(21), 4911-4. ()
    10. Palaniappan KK, Gao ZG, Ivanov AA, Greaves R, Adachi H, Besada P, Kim HO, Kim AY, Choe SA, Jeong LS, Jacobson KA (2007). Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides. Biochemistry, 46(25), 7437-48. ()

    Review

    1. Kim RG, Loomba R, Prokop LJ, Singh S (2017). Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. [Review]. Clin Gastroenterol Hepatol, 15(10), 1521-1530.e8. ()

    Case Report

    1. Kraft C, Kim RG, Kathpalia P (2020). Recurrent Lower Gastrointestinal Bleeding due to a Cholecystocolonic Fistula. Am J Gastroenterol, 116(9), 1825. ()

  • News & Podcasts

    News